Clinical Research Coalition (CRC) Roundtable 1

Following our previous iteration of the Clinical Research Coalition which tackled the unique challenges to clinical research in the UK. These discussions took place in the wake of clinical trial disruptions and sought to explore clinical research in a post-Brexit UK. Now, PPP launches the next phase of our Clinical Research Coalition to explore patient and participant access to clinical trials and focus on increasing public engagement with clinical research. This is a 12-month programme, with one coalition meeting every quarter accompanied by a report publication.

This series will tackle the following topics: how do we better include under-represented groups in clinical research, how can we harness increased public engagement following the pandemic to improve participation, how can we make clinical research participation easier and how can decentralised trials provide more access to clinical trials. For this first session, we will explore how do we better include under-represented groups in clinical research.

This series will be co-chaired by Dr Simon Kolstoe, chair of the Health Research Authority Fast Track research ethics committee and chair of the Research Ethics and Governance Group (REGG) of the UK Health Security Agency and Mr Matthew Shaw, Chief Executive of Great Ormond Street Children’s Hospital NHS Foundation Trust.